Clinical Trial Update: randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing sacubitril/valsartan vs enalapril in chronic heart failure with reduced ejection fraction has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Enalapril (enalapril)
• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Heart Failure With Reduced Ejection Fraction | Phase 3 | Status: COMPLETED | Results posted: 2019-09-16